144 related articles for article (PubMed ID: 12019408)
1. Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody.
Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
Surgery; 2002 May; 131(5):541-7. PubMed ID: 12019408
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Takahashi K; Saito T
Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
5. Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery.
Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
Oncol Rep; 2001; 8(4):815-9. PubMed ID: 11410790
[TBL] [Abstract][Full Text] [Related]
6. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
[TBL] [Abstract][Full Text] [Related]
7. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Sasaki H; Saito T
Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846
[TBL] [Abstract][Full Text] [Related]
9. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
[TBL] [Abstract][Full Text] [Related]
10. Correlation between malignancy grade and p53 gene in relation to thymidine phosphorylase activity in colorectal cancer patients.
Aoki T; Katsumata K; Tsuchida A; Tomioka H; Koyanagi Y
Oncol Rep; 2002; 9(6):1267-71. PubMed ID: 12375032
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma.
Takebayashi Y; Akiyama S; Akiba S; Yamada K; Miyadera K; Sumizawa T; Yamada Y; Murata F; Aikou T
J Natl Cancer Inst; 1996 Aug; 88(16):1110-7. PubMed ID: 8757190
[TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients.
Hasegawa S; Seike K; Koda K; Takiguchi N; Oda K; Hasegawa R; Miyazaki M
Oncol Rep; 2005 Apr; 13(4):621-6. PubMed ID: 15756433
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma.
Suzuki K; Morita T; Hashimoto S; Tokue A
Urol Res; 2001 Feb; 29(1):7-12. PubMed ID: 11310220
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer.
Matsumura M; Chiba Y; Lu C; Amaya H; Shimomatsuya T; Horiuchi T; Muraoka R; Tanigawa N
Cancer Lett; 1998 Jun; 128(1):55-63. PubMed ID: 9652793
[TBL] [Abstract][Full Text] [Related]
17. [Expression of thymidine phosphorylase in human colorectal carcinoma and its clinical significance].
Xiao JX; Sun H; Yang J; Li CL; Han M; Li R
Ai Zheng; 2004 Mar; 23(3):303-5. PubMed ID: 15025963
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase as a prognostic factor in renal cell carcinoma.
Padrik P; Saar H
Int Urol Nephrol; 2010 Jun; 42(2):295-8. PubMed ID: 19572207
[TBL] [Abstract][Full Text] [Related]
19. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
[TBL] [Abstract][Full Text] [Related]
20. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Amano J
Dis Esophagus; 2002; 15(1):67-73. PubMed ID: 12060046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
